StonvexLoading…
StonvexStonvexStonvexCore line items from RXST's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $134.48M | $139.93M | $89.08M | $49.01M |
Operating Income | $-48.19M | $-36.86M | $-50.09M | $-63.32M |
Net Income | $-38.94M | $-27.45M | $-48.61M | $-66.76M |
EPS (Diluted) | $-0.95 | $-0.71 | $-1.41 | $-2.41 |
Total Assets | $311.81M | $318.56M | $182.55M | $150.16M |
Total Liabilities | $36.13M | $37.33M | $22.19M | $60.26M |
Cash & Equivalents | $19.95M | $16.71M | $9.69M | $11.83M |
Free Cash Flow OCF − CapEx | $-19.34M | $-22.39M | $-46.41M | $-61.24M |
Shares Outstanding | 41.24M | 40.43M | 36.14M | 28.27M |